How Body Weight Affects Immune Response to COVID-19
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
ICU mortality rates during the pandemic were significantly lower in ICUs that exhibited high efficiency, pre-COVID-19.
Having a COVID-19 infection is associated with an increased risk of developing Guillain-Barré syndrome within the next six weeks, new research finds.
Scientists suggest that extended ailments, termed “long colds,” can also arise from non-COVID respiratory infections.
Some childhood exposures, such as parental smoking and respiratory tract infections, are risk factors for obstructive sleep apnea in middle-aged adults, researchers find.
An FDA advisory committee determined that phenylephrine, common in brands like Benadryl and Mucinex, is ineffective as a nasal decongestant.
A phase 2 study showed the treatment improved blood oxygen levels and lowered the risk of long-term sensory and motor neurologic symptoms.